Publicaciones en colaboración con investigadores/as de King's College London (21)

2023

  1. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors

    American Journal of Psychiatry

2022

  1. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

    Biological psychiatry, Vol. 91, Núm. 3, pp. 313-327

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2015

  1. The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: A replication study

    Journal of Psychiatry and Neuroscience, Vol. 40, Núm. 3, pp. 187-196

2014

  1. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain

    Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113

2013

  1. A MAOA gene*cocaine severity interaction on impulsivity and neuropsychological measures of orbitofrontal dysfunction: Preliminary results

    Drug and Alcohol Dependence, Vol. 133, Núm. 1, pp. 287-290

  2. Dose-response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sample

    Journal of Psychiatric Research, Vol. 47, Núm. 8, pp. 1036-1043

2011

  1. Pharmacogenetics in psychiatry: The need to prove its benefits

    Revista de Psiquiatria y Salud Mental, Vol. 4, Núm. 3, pp. 117-118

  2. Polymorphic variation at the serotonin 1-A receptor gene is associated with comorbid depression and generalized anxiety

    Psychiatric Genetics, Vol. 21, Núm. 4, pp. 195-201

2009

  1. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use

    Schizophrenia Research, Vol. 107, Núm. 2-3, pp. 158-164

2002

  1. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT1A receptor gene as putative risk factors in major depression [3]

    Molecular Psychiatry

2001

  1. An association study of 5-HT5A and 5-HT3B polymorphisms and olanzapine response

    American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 105, Núm. 7, pp. 641

  2. Genetic variation in the 5-HT5A receptor gene in patients with bipolar disorder and major depression

    Neuroscience Letters, Vol. 303, Núm. 2, pp. 111-114

2000

  1. Antipsychotic response prediction by genotype

    American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 96, Núm. 4, pp. 538

  2. Investigation of 5-HT2A differential expression and imprinting in schizophrenia

    American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 96, Núm. 4, pp. 561

  3. Novel polymorphisms in 5-HT3A receptor gene not related to schizophrenia and clozapine response

    American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 96, Núm. 4, pp. 538

  4. Serotonin-6 (5-HT6) receptor variant (267-C/T) not associated with clozapine response

    American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 96, Núm. 4, pp. 539

1998

  1. Serotonin transporter gene and risk for bipolar affective disorder: An association study in a Spanish population

    Biological Psychiatry, Vol. 43, Núm. 11, pp. 843-847

1997

  1. Genetic variation of the 5-HT(2A) receptor gene and bipolar affective disorder

    Human Genetics, Vol. 100, Núm. 5-6, pp. 582-584

1996

  1. Allelic association analysis of the 5-HT(2C) receptor gene in bipolar affective disorder

    Neuroscience Letters, Vol. 212, Núm. 1, pp. 65-67